The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World

Table 1

Demographics for the 344 respondents who completed the survey. Results are presented as N (%) or median (interquartile range) as appropriate.

Characteristic	N=344
Continent
North America	183 (53%)
Europe	103 (30%)
Asia	20 (6%)
Oceania	21 (6%)
Africa	10 (3%)
South America	7 (2%)
Primary practice type
University-based	248 (72%)
Community-based	96 (28%)
Years in practice following fellowship
<10	184 (53%)
10-20	92 (27%)
20-40	68 (20%)
Percentage of practice devoted to IBD	20 (10-40)
Number of IBD patients in practice	40 (20-90)
Percentage of patients with CD	60 (50-70)
Oldest IBD patient ever treated (years)
≤18	147 (43%)
18-21	93 (27%)
21-25	82 (24%)
25-75	21 (6%)

IBD: inflammatory bowel disease; CD: Crohn’s disease.